A Pilot Study of Topical Imiquimod Therapy for the Treatment of Recurrent Extramammary Paget's Disease

Trial Profile

A Pilot Study of Topical Imiquimod Therapy for the Treatment of Recurrent Extramammary Paget's Disease

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 04 Apr 2017

At a glance

  • Drugs Imiquimod (Primary)
  • Indications Extramammary Paget disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Mar 2017 Planned End Date changed from 1 Apr 2017 to 1 Apr 2018.
    • 29 Mar 2017 Planned primary completion date changed from 1 Apr 2017 to 1 Apr 2018.
    • 22 Apr 2016 Results (n=8) published in the Gynecologic Oncology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top